Sri Lanka

in page functions
[French]
Sri Lanka
Total population (2017) 20,904,160
Birth cohort (2017) 313,630
Surviving Infants (surviving to 1 year per year, 2017) 311,431
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 8/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 10/1000
World Bank Index, IDA (2015) 3.38
Gross Nation Income (per capita US$, 2015) 3,800
Co-financing group (2017) Fully self-financing
No. of districts/territories (2016) 26

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Sri Lanka

Type of support

Approvals

2001-2021 (US$)
(18 Oct 2017)

Commitments

2001-2021 (US$)
(18 Oct 2017)

Disbursements

2000-2017 (US$)
(18 Oct 2017)

% Disbursed

(18 Oct 2017)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Total $28,881,250 $28,881,250 $29,815,891
Graduation grant (GG) $87,004 $87,004 $87,004 100%
Health system strengthening (HSS 1) $4,505,000 $4,505,000 $4,505,000 100%
HepB mono (NVS) $2,486,882 $2,486,882 $2,486,882 100%
HPV (NVS) $1,055,500 $1,055,500 $1,042,250 99%
Injection Safety Devices (NVS) $62,500 $62,500 $75,632 121%
Injection safety support (INS) $709,749 $709,749 $709,749 100%
IPV (NVS) $1,530,481 $1,530,481 $1,454,934 95%
Penta (NVS) $17,530,134 $17,530,134 $18,540,440 106%
Vaccine Introduction Grant (VIG) $914,000 $914,000 $914,000 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Sri Lanka DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 99%
M:F sex ratio at birth (2017) 1.04
Household survey: DTP3 coverage for male (2006) 99.20%
Household survey: DTP3 coverage for female (2006) 99.60%
Household survey: Last DTP3 survey (2006) 100%
% districts achieving > 80% DTP3 coverage (2016) 100%
% districts achieving < 50% DTP3 coverage (2016) 0%
MCV WHO/UNICEF estimates (2016) 99%

Breakdown of support

Non-vaccine support Vaccine support
21% 79%
$6,215,753 $23,600,138

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Sri Lanka

24 October 2017

Bangladesh IPV PCV launch 2015

World Polio Day: Gavi's role in polio eradication

24 October marks World Polio Day, when the global community celebrates the immense progress and considers the work ahead to ensure no child suffers from polio again.

17 October 2017

APR 2016

2016 Report: Gavi adapting to changing global health landscape

Gavi’s 2016 Annual Report illustrates both our progress and how we are adapting to increasingly challenging global trends .

09 September 2017

Twinning Sri Lanka and Timor Leste 1

'Twinning' is winning: landmark Sri Lanka/Timor-Leste immunisation agreement

Sri Lanka to share best practices to help Timor-Leste transition out of Gavi support.

close icon

modal window here